Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study

Purpose Prevalence data on the off-label use (OLU) of anticancer drugs are limited despite OLU being controversial for medical, pharmaco-economic, and ethical reasons. We therefore quantified and characterized the OLU of anticancer drugs and compared OLU based on the national drug label with interna...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2014-06, Vol.70 (6), p.719-725
Hauptverfasser:	Joerger, M., Schaer-Thuer, C., Koeberle, D., Matter-Walstra, K., Gibbons-Marsico, J., Diem, S., Thuerlimann, B., Cerny, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - administration & dosage Antineoplastic Agents - supply & distribution Antineoplastic Agents - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Cohort Studies Descriptive labeling Drug Utilization Review - statistics & numerical data Female Health economics Humans Male Medical ethics Medical sciences Middle Aged Neoplasms - drug therapy Neoplasms - epidemiology Off-Label Use - economics Off-Label Use - statistics & numerical data Pharmacoepidemiology and Prescription Pharmacology Pharmacology. Drug treatments Pharmacology/Toxicology Practice Guidelines as Topic Prescription drugs Prospective Studies Switzerland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!